MA
Manjunath Adiga
About Manjunath Adiga
Data last updated:
Manjunath Adiga is a Managing Director at Medihauxe International India Private Limited (since 2022) and Director at Paterson Cancer Center Private Limited (since 2002). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹351 Cr; the largest is Medihauxe International India Private Limited at ₹348 Cr (FY 2025). Earlier, Manjunath Adiga was a Director at Dhanvanthri Pharma Distributors Private Limited (from 2018) and Managing Director at Medihauxe International Private Limited (from 2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medihauxe International India Private Limited U24299TN2022PTC153849 | Managing Director | 13 Jul 2022 | 2022 | ₹348 Cr (FY 2025) | Active |
 Paterson Cancer Center Private Limited U85110TN2000PTC045194 | Director | 28 Nov 2002 | 2000 | ₹2.98 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Dhanvanthri Pharma Distributors Private Limited U51909TN2018PTC124820 | Director | 06 Dec 2018 | 2018 | ₹1.6 Lakh (FY 2022) | Strike Off |
| Medihauxe International Private Limited U24233TG2009PTC169181 | Managing Director | 05 Feb 2010 | 2009 | ₹235 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manjunath Adiga
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Kumar Venkat | 02304618 | Medihauxe International India Private Limited | Director |
| Gaurav Chaturvedi | 06938743 | Medihauxe International India Private Limited | Director |
| Palepu Srinivasa Gopal | 00633287 | Medihauxe International India Private Limited | Director |
| Yogesh Dayama | Medihauxe International India Private Limited | Company Secretary | |
| Srinivasan Krishnan | 10157065 | Paterson Cancer Center Private Limited | Director |
| Srinivasan Vijayaraghavan | 00052835 | Paterson Cancer Center Private Limited | Managing Director |
| Subramanian Aiyer Vembu | 00270461 | Paterson Cancer Center Private Limited | Additional Director |
| Usha Vijayaraghavan | 06528071 | Paterson Cancer Center Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manjunath Adiga
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manjunath Adiga
Manjunath Adiga currently holds 2 directorships: Medihauxe International India Private Limited (Managing Director, since 13 Jul 2022, revenue ₹348 Cr (FY 2025)); Paterson Cancer Center Private Limited (Director, since 28 Nov 2002, revenue ₹2.98 Cr (FY 2025)).
Manjunath Adiga was first appointed on 28 Nov 2002 as Director at Paterson Cancer Center Private Limited. The most recent appointment on record is 13 Jul 2022 at Medihauxe International India Private Limited.
The 2 current companies of Manjunath Adiga that report revenue have a combined latest revenue of ₹351 Cr: Medihauxe International India Private Limited ₹348 Cr (FY 2025); Paterson Cancer Center Private Limited ₹2.98 Cr (FY 2025).
Manjunath Adiga held 2 earlier board appointments: Dhanvanthri Pharma Distributors Private Limited (Director, from 06 Dec 2018); Medihauxe International Private Limited (Managing Director, from 05 Feb 2010).
The current boards of Manjunath Adiga's companies include Arvind Kumar Venkat (Medihauxe International India Private Limited), Gaurav Chaturvedi (Medihauxe International India Private Limited), Palepu Srinivasa Gopal (Medihauxe International India Private Limited), Yogesh Dayama (Medihauxe International India Private Limited), Srinivasan Krishnan (Paterson Cancer Center Private Limited), Srinivasan Vijayaraghavan (Paterson Cancer Center Private Limited), among others.